TipRanks
Mosaic Co (MX:MOS)
:MOS
Mexico Market
EarningsQ2 2026 Earnings Report

Mosaic Co (MOS) Q2 2026 Earnings Report

1 Followers

MX:MOS Q2 2026 EPS Results

Actual EPS$2.35
Consensus EPS$2.19
Beat/MissBeat by +$0.16
One Year Ago EPS$9.23

MX:MOS Q2 2026 Revenue Results

Actual Revenue$51.10B
Expected Revenue$56.09B
Beat/MissMissed by -$4.98B
YoY Revenue Growth-6.04%

Earnings Announcement Details

QuarterQ2 2026
Date05/11/2026
TimeAfter Close
Conference CallMonday, May 11, 2026
MX:MOS Upcoming Earnings
Mosaic Co's next earnings date is estimated for November 10, 2026, based on past reporting schedules.

Q2 2026 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q2 2026 Earnings Slide Deck

Q2 2026 Earnings Call Summary

Q2 2026
Earnings Call Date:May 11, 2026|
% Change Since:
|
Earnings Call Sentiment|Neutral
Mixed. The call details significant near-term challenges driven primarily by external sulfur supply disruptions and resulting phosphate curtailments, under-application of phosphate (driving agronomic risk) and some near-term cash pressure (approx. $500M expected shortfall). Offsetting these negatives are multiple company actions and strengths: secured sulfur contracts materially below spot for Q3, strong balance sheet and liquidity actions (term loan, refinancings, untapped revolver), meaningful SG&A reductions (-20% YoY), potash stability and growth projects (Esterhazy HydroFloat), resilient Brazil distribution and co-product margins, fast-growing Mosaic Biosciences, lower CapEx guidance ($1.2B) and an expected working capital release (forecast $300–500M) supporting sequential free cash flow improvement in Q3 and Q4. Overall the transcript portrays a company taking decisive defensive actions to manage a severe but (management believes) temporary market disruption, leading to a balanced view of risk and mitigation.
Company Guidance
Mosaic guided third-quarter realized raw‑material costs of about $700–710/ton for sulfur and $610–620/tonne for ammonia (Q2 averages were $522/ton sulfur and $621/tonne ammonia), DAP FOB pricing of $820–840/tonne and implied stripping margins “well above” historical averages; phosphate sales guidance for Q3 was 1.1–1.4 million tonnes (Q2 produced/sold 1.4M t) and Q2 realized stripping margin was $422/tonne. They cut full‑year CapEx to $1.2B (from $1.25B/$1.5B prior) with roughly $300M expected in Q3 and a drop in Q4, reduced SG&A ~20% YoY with further declines forecast, and expect sequential free‑cash‑flow improvement in Q3 and Q4. Mosaic reiterated a $300–500M working‑capital release this year (≈$100–200M in Q3, majority in Q4), Q2 Fertilizantes EBITDA ≈$60M, Q2 MOP costs $84/ton (lower in H2), Biosciences on track to double revenues with ~ $30M Brazil sales in Q3 (~40% margin, ≈$12M contribution), Q2 idle/turnaround charges ≈$60M with Q3 incremental idle/turnaround of roughly $10–20M, and strengthened liquidity via a $1.0B term loan, $500M CP refinanced in June (remainder in July) and an untapped $2.5B revolver.
Q2 Production and Sales
Produced and sold 1.4 million tonnes of phosphate in Q2 despite market turmoil, demonstrating operational flexibility and strong global customer relationships.
Raw Material and Margin Metrics (Q2 & Guidance)
Q2 average raw material costs: sulfur $522 per long ton, ammonia $621 per tonne; achieved an average realized stripping margin of $422 per tonne in Q2. For Q3 management guided realized sulfur costs of ~$700–710/ton and ammonia ~$610–620/ton with DAP FOB pricing guidance $820–840/ton, implying an implied realized stripping margin well above historical averages.
Sulfur Contracting Success
Locked in a significant portion of third-quarter U.S. sulfur supply at $705/ton (well below current spot), preserving advantaged feedstock access versus the broader market.
Potash Stability and Growth Projects
Potash supply/demand balanced: summer fill program fully subscribed, strong demand driven by palm oil economics and Chinese inventory replenishment. Q2 MOP costs were $84/tonne; Esterhazy annual turnaround completed and HydroFloat project expected to lower unit costs and add volumes.
Brazil Fertilizantes Resilience
Fertilizantes generated ~$60 million of EBITDA in Q2 despite widespread curtailments, indicating resilience of the Brazilian franchise with distribution and co-product sales (e.g., gypsum) supporting margins.
Cost and SG&A Reductions
SG&A declined ~20% year-over-year due to spending discipline, reduced support labor, lower bad debt, and benefits from divestitures; management expects further SG&A declines in H2 and permanent structural savings.
Liquidity and Balance Sheet Actions
Fortified liquidity: $1 billion term loan put in place to replace short-term commercial paper, $500 million CP refinanced in June (rest in July), untapped $2.5 billion revolver available; management expects indebtedness roughly stable in Q3 and to decline in Q4.
Working Capital and Cash Flow Outlook
Management expects working capital release of $300–500 million for the year (midpoint ~$400M); anticipated Q3 working capital release of $100–200M and sequential free cash flow improvement in Q3 and Q4. Full-year CapEx guidance lowered to $1.2 billion (from prior $1.25B and initial $1.5B).
Biosciences and Portfolio Optimization
Mosaic Biosciences is fast-growing and on track to double revenues again this year; Q3 Brazil Biosciences sales expected ~ $30 million with ~40% contribution margin (~$12 million contribution). Closed Carlsbad sale; advancing Araxa divestiture process and reallocating capital to higher-return opportunities (including Rainbow REE project).
Inventory Trends
Finished goods inventory reduced from ~1.0 million tonnes to ~600–700k tonnes (healthier level); management expects physical inventories to trend down, particularly raw materials and rock inventories as curtailments continue.
Operational Readiness and Ramp Capability
Extensive fortification work over prior 18 months positions the company to ramp back to full production rates quickly (management indicated ramp could take weeks once raw material constraints ease).

MX:MOS Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Nov 10, 2026
2026 (Q3)
0.90 / -
18.819―
2026 (Q1)
4.43 / 0.90
8.867-89.80% (-7.96)
2026 (Q2)
2.19 / 2.35
9.229-74.51% (-6.88)
2025 (Q4)
8.81 / 3.98
8.143-51.11% (-4.16)
2025 (Q3)
17.52 / 18.82
6.152205.88% (+12.67)
2025 (Q2)
13.17 / 9.23
9.771-5.56% (-0.54)
2025 (Q1)
8.14 / 8.87
11.762-24.62% (-2.90)
2024 (Q4)
10.31 / 8.14
12.848-36.62% (-4.70)
2024 (Q3)
9.39 / 6.15
12.305-50.00% (-6.15)
2024 (Q2)
11.98 / 9.77
18.819-48.08% (-9.05)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed